Technology That Mimics the Immune System
Joshua McClure is CEO, Co-founder, and Co-inventor of Maxwell Biosciences, a preclinical drug platform company that develops biomimetic therapeutics – synthetic compounds that mimic and improve upon biomolecules. Today he discusses Maxwell’s first-in-class, CLAROMER™ brand drug platform that has been shown to be effective in destroying viruses, bacteria, fungi, and some cancers, while safely avoiding healthy cells. The compounds imitate key components of the immune system, humanity’s greatest asset in fighting disease.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Joshua McClure is CEO, Co-founder, and Co-inventor of Maxwell Biosciences, a preclinical drug platform company that develops biomimetic therapeutics – synthetic compounds that m…
- Key Point: Today he discusses Maxwell’s first-in-class, CLAROMER™ brand drug platform that has been shown to be effective in destroying viruses, bacteria, fungi, and some cancers, while …
- Key Point: The compounds imitate key components of the immune system, humanity’s greatest asset in fighting disease. A graduate of the United States Air Force Academy, Joshua has over …
- Key Point: He is a multi-patent innovator with a background in military and commercial intelligence and now devotes his time to biotechnologies.
- Key Point: His knowledge of leadership principles alongside his 2016 big data study of immune proteins’ impact on health outcomes are the foundation of the company.
A graduate of the United States Air Force Academy, Joshua has over 20 years of experience as a CEO. He is a multi-patent innovator with a background in military and commercial intelligence and now devotes his time to biotechnologies. His knowledge of leadership principles alongside his 2016 big data study of immune proteins’ impact on health outcomes are the foundation of the company.
In 2015, Joshua dedicated himself to combating pathogens – the leading cause of human disease and mortality. He co-invented the world’s first tissue-safe virucidal anti-infectives, anti-infective device coatings, the first antiviral condom, human gene expression modulation technology, geo-placed digital media, facial recognition-based commerce, and designed and commercialized the world’s first dual core laptop computer in partnership with Advanced Micro Devices.
Prior to Maxwell, Joshua was the CEO and founder of RealMassive, the real estate industry’s largest source of commercial property data.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



